(Q33920752)

30 July 2017

1 reference

title

Progress with retroviral gene vectors (English)

1 reference

30 July 2017

Palù G

1

1 reference

30 July 2017

Parolin C

series ordinal

2

1 reference

30 July 2017

Takeuchi Y

series ordinal

3

1 reference

30 July 2017

Pizzato M

series ordinal

4

1 reference

30 July 2017

language of work or name

1 reference

1 May 2000

1 reference

Reviews in Medical Virology

30 July 2017

published in

1 reference

30 July 2017

volume

10

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

185-202

1 reference

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Viral RNA-dependent DNA polymerase RNA-dependent DNA polymerase in virions of Rous sarcoma virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Active nuclear import of human immunodeficiency virus type 1 preintegration complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5' long terminal repeat and the start of the gag gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Factors involved in production of helper virus-free retrovirus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

A transient three-plasmid expression system for the production of high titer retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

A novel human amphotropic packaging cell line: high titer, complement resistance, and improved safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Comparison of promoter suppression in avian and murine retrovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Generation of retroviral vector for clinical studies using transient transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Production of high-titer helper-free retroviruses by transient transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Human serum lyses RNA tumour viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Development of amphotropic murine retrovirus vectors resistant to inactivation by human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Retroviral vector producer cell killing in human serum is mediated by natural antibody and complement: strategies for evading the humoral immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Complement-protected amphotropic retroviruses from murine packaging cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

MuLV-based vectors pseudotyped with truncated HIV glycoproteins mediate specific gene transfer in CD4+ peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Antibody-mediated binding of a murine ecotropic Moloney retroviral vector to human cells allows internalization but not the establishment of the proviral state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Ligand-directed retroviral targeting of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Targeted infection of a retrovirus bearing a CD4-Env chimera into human cells expressing human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Retroviral vectors displaying functional antibody fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Targeting strategy for gene delivery to carcinoembryonic antigen-producing cancer cells by retrovirus displaying a single-chain variable fragment antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Retroviral vector targeting human cells via c-Kit-stem cell factor interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Gene therapy for cancer: what have we done and where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Gene marking and autologous bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Viral protein R regulates nuclear import of the HIV-1 pre-integration complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Use of cis- and trans-acting viral regulatory sequences to improve expression of human immunodeficiency virus vectors in human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Regulated lentiviral packaging cell line devoid of most viral cis-acting sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Human immunodeficiency virus type 2 lentivirus vectors for gene transfer: expression and potential for helper virus-free packaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Transduction of human macrophages using a stable HIV-1/HIV-2-derived gene delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Gene transfer vectors derived from equine infectious anemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Stable gene transfer to the nervous system using a non-primate lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

The molecular basis of HIV capsid assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Direct Interaction of Complement Factor H with the C1 Domain of HIV Type 1 Glycoprotein 120

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

A gene delivery system activatable by disease-associated matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200005%2F06%2910%3A3%3C185%3A%3AAID-RMV285%3E3.0.CO%3B2-8

10.1002/(SICI)1099-1654(200005/06)10:3<185::AID-RMV285>3.0.CO;2-8

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference